G. Kirk Domescik is the managing partner of Duane Morris LLP’s Atlanta office and a prominent practitioner in healthcare and corporate transactional law. Operating at the intersection of regulatory compliance and high-stakes capital deployment, Domescik orchestrates mergers, acquisitions, and private equity roll-ups across both the medical sector and middle-market industries. His practice is defined by navigating complex statutory frameworks, such as the Corporate Practice of Medicine (CPOM) doctrine and federal fraud statutes (including the Stark Law and Anti-Kickback Statute), enabling institutional buyers to consolidate fragmented markets. Core legal stakes involve the intricate transfer of multi-jurisdictional licensing, Medicare certification continuity, and the strict enforcement of post-sale restrictive covenants in transitions of corporate ownership. Key data points of his representation include managing over two dozen physician practice sales to private equity-backed management services organizations, structuring major hospital expansions spanning multi-county regions, and facilitating broad middle-market trades consolidation, such as an aftermarket warranty buyout exceeding $50 million and multiple roofing platform acquisitions ranging from $19.5 million to $31 million.

The Architecture of Capital and Consolidation

The modern American economy is undergoing a quiet, relentless transformation. Across the country, independent medical practices, regional acute-care hospitals, and family-owned trades are being systematically absorbed into larger corporate networks and private equity portfolios. This migration of ownership does not happen by gravity; it requires highly specialized legal architecture to navigate the labyrinth of federal regulations, state licensing boards, and antitrust scrutiny. G. Kirk Domescik, the managing partner of Duane Morris LLP’s Atlanta office, operates as a premier architect of this consolidation.

Practicing at the intersection of healthcare law and high-stakes corporate transactions, Domescik represents the forces of capital and the founders seeking a liquidity event. His practice focuses heavily on mergers and acquisitions, private equity deployments, and complex corporate governance. Whether drafting the surviving bylaws for an absorbed community hospital or structuring the buyout of a residential garage door servicer, Domescik’s work defines how businesses transition from private independence to corporate or fund-backed ownership.

For nearly three decades, beginning with his graduation cum laude from the University of Georgia School of Law in 1994, Domescik has guided inception-stage ventures and legacy corporations through the mechanics of capital acquisition and divestiture. While public attention is often drawn to courtroom litigation, the most permanent shifts in community power and economic structure occur in the boardrooms where Domescik operates. By facilitating multi-million-dollar private equity buyouts and sprawling hospital mergers, his practice highlights the accelerating corporatization of both healthcare and middle-market American enterprise.

Restructuring the Healthcare Landscape

Healthcare is arguably the most heavily regulated industry in the United States. When a corporation or a private equity fund attempts to purchase a medical facility or a hospital network, they cannot simply transfer a deed and swap out the corporate signage. They must navigate a minefield of federal statutes, state health department regulations, Medicare certification transfers, and stringent oversight regarding patient data and continuity of care. Domescik has built a formidable reputation by steering massive institutional providers through this regulatory gauntlet.

His representation in the hospital sector demonstrates a deep understanding of how non-profit and for-profit healthcare systems absorb regional competitors. The stakes in these transactions are incredibly high; the survival of local acute care, the employment of thousands of medical professionals, and the distribution of regional healthcare access all hinge on the legal scaffolding of the deal.

Domescik’s representative matters in this arena illustrate the scale of his healthcare practice:

• The WellSpan Health Expansion: Domescik represented WellSpan Health in its acquisition of Evangelical Community Hospital. This transaction was not a simple asset purchase; it was a strategic regional expansion that extended WellSpan’s network of care across twelve counties spanning Central Pennsylvania and Northern Maryland.
• The Temple Health Acquisition: Serving as lead healthcare mergers and acquisitions counsel, Domescik represented Temple Health in its acquisition of a Pennsylvania acute care hospital. This deal was forged through a highly competitive bidding process, requiring Domescik to negotiate the foundational hospital affiliation agreement and draft the bylaws for the newly formed purchaser entity.
• Diagnostic Imaging Joint Ventures: Domescik has served as counsel to a national developer and manager of diagnostic imaging facilities. He structured multiple joint ventures between this developer and established hospital systems, while also guiding the client through the acquisition of independent imaging centers.

These transactions require more than basic contract negotiation. When a hospital system acquires a community facility, the transaction must survive scrutiny from state attorneys general, who are tasked with ensuring that charitable assets are not improperly liquidated and that the consolidation will not create local monopolies that drive up patient costs. By negotiating the affiliation agreements and bylaws, Domescik ensures that the acquiring entity secures the necessary control to justify the massive capital expenditure, while strictly adhering to the regulatory frameworks demanded by state and federal health authorities.

The Private Equity Roll-Up of Physician Practices

Perhaps the most profound shift in modern healthcare is the rapid entry of private equity into specialized physician practices. Historically, doctors owned their own clinics, operated independently, and eventually sold their practices to junior partners. Today, private equity funds are executing aggressive “roll-up” strategies—buying dozens of regional practices, centralizing their billing, management, and supply chains to increase profit margins, and eventually selling the consolidated platform to a larger fund.

This strategy faces a massive legal obstacle: the Corporate Practice of Medicine (CPOM) doctrine. Many states legally prohibit general corporations or private equity funds from employing physicians or owning medical practices, a rule designed to prevent corporate profit motives from interfering with independent medical judgment. To bypass this restriction, private equity firms rely on sophisticated legal structures, and Domescik is a veteran navigator of this specific doctrine.

To facilitate these acquisitions, transactional attorneys implement a bifurcated operational model known as a Management Services Organization (MSO) structure. Under this framework, the private equity fund buys all the non-clinical assets of a practice—the real estate, the medical equipment, the intellectual property, and the billing systems. The fund then establishes an MSO. Meanwhile, the actual clinical practice is maintained by a professional corporation (PC) that is technically owned by a physician friendly to the corporate buyer. The MSO then enters into a long-term, highly lucrative management agreement with the PC, effectively extracting the profit of the medical practice without technically violating the CPOM doctrine.

Domescik has represented over two dozen separate physician practices in the sale of their assets to private equity-backed management services organizations. His work in this sector has spanned a wide array of high-margin medical specialties, including:

• Ophthalmology and optometry services (Specifically, this practice area includes matters such as the $1,168,893 project transaction involving the Eye Surgery Center of Georgia, LLC ).
• Ear, nose, and throat (ENT) and allergy clinics (
  

  Navigating the Fraud and Abuse Minefield

Beyond the CPOM doctrine, healthcare transactions are shadowed by the constant threat of federal prosecution. Domescik frequently advises healthcare providers, buyers, and investors on the severe operational impact of the Stark Law and federal fraud and abuse laws, particularly the Anti-Kickback Statute.

In standard corporate environments, providing discounts, volume rebates, or referral bonuses is considered routine business strategy. In the healthcare sector, these same practices can constitute federal felonies if they involve Medicare or Medicaid funds. The Stark Law, a strict-liability statute, prohibits physicians from referring Medicare patients for designated health services to any entity with which the physician has a financial relationship, unless a specific statutory exception is met. The Anti-Kickback Statute similarly criminalizes the exchange of anything of value to induce referrals of federal healthcare program business.

When Domescik structures a joint venture between a hospital and a diagnostic imaging center, or when he facilitates a private equity buyout of a pain management clinic, he must build structural firewalls that comply with these labyrinthine federal statutes. Every medical director agreement, every office lease, and every equipment rental must be rigorously documented to prove it represents fair market value and is commercially reasonable absent any referrals. A failure in this legal architecture can result in the catastrophic unwinding of the business, exclusion from federal healthcare programs, and devastating financial penalties.

Long-Term Care and Multi-State Capital

The aging American population has transformed long-term care into a prime target for institutional investment. Domescik has developed substantial experience advising both the owners and the corporate operators of long-term care communities. He specializes in the acquisition and divestiture of assisted living facilities and skilled nursing facilities, structures that frequently require intricate real estate financing arrangements.

These transactions are uniquely complicated because they straddle real estate law and healthcare regulation. Purchasing a skilled nursing facility requires navigating state-specific Certificate of Need (CON) laws, which strictly limit the number of licensed beds allowed in a given region to prevent market saturation. When representing multiple investment groups in multi-state acquisitions of these facilities, Domescik must sequence the transfer of real estate alongside the transfer of state operational licenses and federal Medicare/Medicaid provider numbers, ensuring that the facility never loses its ability to bill the government during the transition of ownership. He has further represented an international security company in the divestiture of its residential-based juvenile services subsidiary—operating across Florida, Texas, and Tennessee—to a Florida-based private equity firm, demonstrating his capacity to handle specialized, multi-jurisdictional regulatory compliance.

Middle-Market Exits and Home Services Roll-Ups

While his healthcare practice is deeply specialized, Domescik’s corporate transaction work extends aggressively into the broader middle market. Private equity capital is no longer restricted to software companies and massive healthcare networks; it has moved decidedly into the fragmented, blue-collar industries of middle America. Domescik frequently serves as lead counsel for founders of blue-collar and home-services companies who are selling their businesses to private equity-backed platform buyers.

In recent years, his representative matters in this space have included:

• The Auto-Warranty Liquidity Event: Domescik represented a leading provider of aftermarket warranty products and services for owned and leased motor vehicles. He structured the sale of a majority equity stake to a global private equity firm, securing an aggregate consideration in excess of $50 million for the sellers.
  

  Institutional Stewardship and Recognition

Beyond his active transactional practice, Domescik is a central figure in the institutional management of the defense bar. In July 2013, he was appointed as the managing partner of Duane Morris’s Atlanta office, succeeding Louis Norwood “Woody” Jameson. In this role, Domescik assumed responsibility for the strategic growth and operational management of the firm’s presence in the Southeast, guiding a large roster of attorneys who represent domestic and international corporate clients.

His influence on corporate law is reflected in consistent industry recognition. He has been listed in Best Lawyers in America from 2021 through 2026 and was recognized in the 2025 edition of Chambers USA. The financial legal directory IFLR1000 has repeatedly rated him as “Highly Regarded” for his work in mergers and acquisitions. Most notably, the Daily Report honored Domescik as a “Most Effective Deal Maker” during the 2023 Southeastern Legal Awards, cementing his status as a dominant architect of regional corporate transactions. While public directories and the award citation do not explicitly state the precise transaction or portfolio of deals that triggered this specific 2023 award, it reflects his overarching volume in middle-market corporate consolidation and healthcare mergers.

Domescik, who earned his undergraduate degree from Duke University before attending the University of Georgia, remains highly active in the broader legal community. He frequently lectures on corporate law, delivering presentations to industry groups on subjects ranging from the merging of non-profit corporations to the strategic enforcement of restrictive covenants and non-solicitation agreements. Furthermore, he serves as an advisory committee member and volunteer attorney for the Pro Bono Partnership of Atlanta, lending his transactional expertise to non-profit organizations navigating their own corporate governance challenges.

Through his orchestration of hospital mergers, his structuring of complex private equity roll-ups, and his navigation of federal healthcare fraud statutes, G. Kirk Domescik continues to reshape the corporate realities of the Southeast. His practice is a testament to the immense power of transactional law—not in the noisy theater of the courtroom, but in the quiet, decisive drafting of the agreements that dictate who owns, operates, and profits from the foundational services of the modern economy.